Real Content Integrity & Artificial Intelligence: The Evolving Role of Medical Review in Digital Transformation
Medical Affairs is rethinking medical review amid AI and digital transformation, balancing speed, rigor, and compliance.
Medical Affairs is rethinking medical review amid AI and digital transformation, balancing speed, rigor, and compliance.
This article summarizes an engaging Roundtable discussion, emphasizing the transformative influence of metrics, data, and technology, particularly Artificial Intelligence (AI), on the strategic role of Medical Affairs.
MedTech Medical Affairs is evolving from a traditional support role into a more strategic function, as leaders look to standardize responsibilities and align workflows across the field.
This article by CCC summarizes their MAPS 2026 Roundtable on literature monitoring in Medical Affairs. It includes aspects on the most pressing workflow challenges, evolving perspective in AI, and copyright considerations.
This article by CCC summarizes their MAPS 2026 Roundtable on literature monitoring in Medical Affairs. It includes aspects on the most pressing workflow challenges, evolving perspective in AI, and copyright considerations.
Medical Affairs teams produce more content than HCPs can consume. This article by Costello Medical explores how to cut content waste through insight-led planning, modular design, smart omnichannel personalisation, and impact-focused measurement — translating efficiency into better scientific exchange and patient outcomes.”
How Medical Affairs teams can break free from insights bottlenecks using AI — moving from reactive reporting to proactive, curiosity-driven strategic intelligence.
A white paper examining the “listening gap” in medical affairs and outlining how biopharma companies can use AI, process standardization, and cross-functional accountability to turn medical insights into measurable impact.
Altmetric’s top 10 most interesting publications of 2025
A white paper examining the “listening gap” in medical affairs and outlining how biopharma companies can use AI, process standardization, and cross-functional accountability to turn medical insights into measurable impact.
